The national drug controller, Drug Controller General of India (DCGI), has approved a new oral therapy drug for multiple sclerosis, developed by Biogen Idec Biotech India. The company has received approval for the first oral therapy drug for multiple sclerosis, Tecfidera by the DCGI. Biogen Idec India Acting Managing Director Pooja Vatsyayan said, "We believe Tecfidera provides a new option for patients in India, particularly as it provides the convenience ...
No comments:
Post a Comment